AB
CTKB icon

Amalgamated Bank’s Cytek Biosciences CTKB Stock Holding History

Amalgamated Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139K Sell
31,901
-535
-2% -$2.53K ﹤0.01% 1592
2025
Q4 		$164K Buy
32,436
+502
+2% +$2.33K ﹤0.01% 1607
2025
Q3 		$111K Buy
31,934
+2,003
+7% +$7.52K ﹤0.01% 1682
2025
Q2 		$102K Buy
29,931
+715
+2% +$2.38K ﹤0.01% 1690
2025
Q1 		$117K Sell
29,216
-2,626
-8% -$13.6K ﹤0.01% 1642
2024
Q4 		$207K Buy
31,842
+964
+3% +$5.74K ﹤0.01% 1568
2024
Q3 		$171K Buy
30,878
+1,608
+5% +$9.12K ﹤0.01% 1610
2024
Q2 		$163K Sell
29,270
-3,593
-11% -$21.6K ﹤0.01% 1622
2024
Q1 		$221K Sell
32,863
-10,654
-24% -$84.3K ﹤0.01% 1576
2023
Q4 		$397K Sell
43,517
-4,971
-10% -$31.3K ﹤0.01% 1531
2023
Q3 		$268K Buy
48,488
+5,957
+14% +$47.8K ﹤0.01% 1672
2023
Q2 		$363K Buy
42,531
+26,599
+167% +$239K ﹤0.01% 1582
2023
Q1 		$146K Sell
15,932
-2,394
-13% -$25.8K ﹤0.01% 1913
2022
Q4 		$187K Hold
18,326
– – ﹤0.01% 1886
2022
Q3 		$270K Buy
18,326
+291
+2% +$3.78K ﹤0.01% 1726
2022
Q2 		$194K Buy
18,035
+2,810
+18% +$28K ﹤0.01% 1894
2022
Q1 		$164K Buy
+15,225
New +$206K ﹤0.01% 2016

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's CTKB Position: Q1 2026 in Review

Amalgamated Bank reduced its Cytek Biosciences (CTKB) stake by 1.6% in Q1 2026, selling an estimated $2.53K and leaving 31,901 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Amalgamated Bank first reported a position in CTKB in Q1 2022 and has held it in 17 quarters since. The position peaked at $397K in Q4 2023. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Amalgamated Bank held 31,901 shares of Cytek Biosciences worth $139K as of Q1 2026.
  • Amalgamated Bank sold 535 Cytek Biosciences shares in Q1 2026, an estimated $2.53K.
  • Cytek Biosciences made up ﹤0.01% of Amalgamated Bank's portfolio in Q1 2026, its #1592 holding.
  • Amalgamated Bank first reported a position in Cytek Biosciences in Q1 2022 and has held it in 17 quarters since.
  • Amalgamated Bank's Cytek Biosciences position peaked at $397K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.